Piroxicam

Discontinued Product

0960 has been discontinued.

View all Cyclooxygenases products.
说明: Cyclooxygenase-1 (COX-1) inhibitor
化学名: 3,4-Dihydro-2-methyl-4-oxo-N-2-pyridyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
纯度: ≥99% (HPLC)
说明书
引用文献
评论
文献 (2)

生物活性 for Piroxicam

Piroxicam is an anti-inflammatory; highly selective inhibitor of COX-1 (ratio of IC50 values for COX-2/COX-1 ~ 600).

技术数据 for Piroxicam

分子量 331.35
公式 C15H13N3O4S
储存 Store at RT
纯度 ≥99% (HPLC)
CAS Number 36322-90-4
PubChem ID 54676228
InChI Key QYSPLQLAKJAUJT-UHFFFAOYSA-N
Smiles CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=C(C=CC=C2)S1(=O)=O

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

产品说明书 for Piroxicam

分析证书/产品说明书
选择另一批次:

参考文献 for Piroxicam

参考文献是支持产品生物活性的出版物。

Mitchell et al (1995) Cyclooxygenase-2. Regulation and relevance in inflammation. Biochem.Pharmacol. 50 1535 PMID: 7503754

Merck Index 12 7661

按标靶查看相关产品

按产品操作查看相关产品

查看全部 Cyclooxygenase Inhibitors

关键词: Piroxicam, Piroxicam supplier, Cyclooxygenase, COX-1, inhibitors, inhibits, COX, Oxygenases, Oxidases, 0960, Tocris Bioscience

篇 Piroxicam 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 Piroxicam 的引用文献。

Piroxicam 的评论

目前没有该产品的评论。 Be the first to review Piroxicam and earn rewards!

Have you used Piroxicam?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Alzheimer's Disease Poster

Alzheimer's Disease Poster

Alzheimer's disease (AD) is a debilitating and progressive neurodegenerative disease and the most common cause of dementia, affecting approximately 30% of individuals aged over 85 years. This poster summarizes the cellular and molecular mechanisms of AD.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.